Find Grants for Large Businesses
Find out if you qualify for verified grants for Large Businesses . Discover your eligibility and key funding details for Large Businesses from major foundations and government agencies.
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-24-304
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Occupational Safety and Health Education and Research Centers (T42)
Deadline: October 26, 2028
Opportunity Number: RFA-OH-25-002
Agency: Centers for Disease Control and Prevention - ERA
Open Date: October 7, 2024
Close Date: October 26, 2028
Status: Posted
CFDA Numbers: 93.262
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PA-25-093
Agency: National Institutes of Health
Open Date: October 4, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855, 93.846
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-050
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.853
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-055
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.853
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
Deadline: September 29, 2027
Opportunity Number: PAR-25-020
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: September 29, 2027
Status: Posted
CFDA Numbers: 93.173
SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY
Deadline: September 29, 2029
Opportunity Number: DE-FOA-0003467
Agency: Advanced Research Projects Agency Energy
Open Date: October 2, 2024
Close Date: September 29, 2029
Status: Posted
CFDA Numbers: 81.135
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: August 18, 2027
Opportunity Number: PAR-24-293
Agency: National Institutes of Health
Open Date: October 1, 2024
Close Date: August 18, 2027
Status: Posted
CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866
Fundamental Research to Counter Weapons of Mass Destruction
Deadline: September 30, 2034
Opportunity Number: HDTRA1-25-S-0001
Agency: Defense Threat Reduction Agency
Open Date: October 1, 2024
Close Date: September 30, 2034
Status: Posted
CFDA Numbers: 12.351
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PA-25-080
Agency: National Institutes of Health
Open Date: October 1, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
Deadline: March 10, 2026
Opportunity Number: RFA-DA-26-009
Agency: National Institutes of Health
Open Date: September 30, 2024
Close Date: March 10, 2026
Status: Posted
CFDA Numbers: 93.279
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
Deadline: March 10, 2026
Opportunity Number: RFA-DA-26-010
Agency: National Institutes of Health
Open Date: September 30, 2024
Close Date: March 10, 2026
Status: Posted
CFDA Numbers: 93.279
Atmosphere Cluster
No deadline specified
Opportunity Number: PD-24-7790
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
Geospace Cluster
No deadline specified
Opportunity Number: PD-24-7789
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
Infrastructure Cluster
No deadline specified
Opportunity Number: PD-24-7791
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Deadline: June 15, 2027
Opportunity Number: RFA-MH-26-120
Agency: National Institutes of Health
Open Date: September 25, 2024
Close Date: June 15, 2027
Status: Posted
CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: August 18, 2026
Opportunity Number: PAR-25-051
Agency: National Institutes of Health
Open Date: September 25, 2024
Close Date: August 18, 2026
Status: Posted
CFDA Numbers: 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: January 20, 2026
Opportunity Number: RFA-NS-25-018
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: January 20, 2026
Status: Posted
CFDA Numbers: 93.173, 93.242, 93.853, 93.867, 93.279, 93.866, 93.273, 93.213, 93.865, 93.286
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
Deadline: January 20, 2026
Opportunity Number: RFA-NS-25-017
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: January 20, 2026
Status: Posted
CFDA Numbers: 93.865, 93.273, 93.213, 93.286, 93.853, 93.173, 93.866, 93.242, 93.279, 93.867
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
Deadline: September 25, 2027
Opportunity Number: PAR-24-301
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: September 25, 2027
Status: Posted
CFDA Numbers: 93.865
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
Deadline: September 9, 2027
Opportunity Number: PAR-24-298
Agency: National Institutes of Health
Open Date: September 20, 2024
Close Date: September 9, 2027
Status: Posted
CFDA Numbers: 93.279
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Deadline: January 15, 2027
Opportunity Number: RFA-NS-25-023
Agency: National Institutes of Health
Open Date: September 18, 2024
Close Date: January 15, 2027
Status: Posted
CFDA Numbers: 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-24-297
Agency: National Institutes of Health
Open Date: September 17, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279
Multilateral Partnerships Leveraging Excellence
No deadline specified
Opportunity Number: PD-24-7298
Agency: U.S. National Science Foundation
Open Date: September 14, 2024
Status: Posted
CFDA Numbers: 47.079
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-275
Agency: National Institutes of Health
Open Date: September 11, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
